From Empower injection to Empower ODT Switching from injection to the oral disintegrating tablet is more complex because bioavailability likely differs between the two routes
To activate its intended effect, it must be taken first thing in the morningon an empty stomach
Getting this wrong means either wasting resources on insufficient doses or risking side effects from excessive administration
Full-length thymosin beta-4 has been through randomized, placebo-controlled human trials but as an ophthalmic solution for dry eye and neurotrophic keratopathy, where it met efficacy endpoints
Patients may have residual gastric contents despite following standard preoperative fasting guidelines
Kwon S-K, Sando IIIR, Lewis TL, Hirabayashi Y, Maximov A, Polleux F